SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Conceptus (CPTS) -- Ignore unavailable to you. Want to Upgrade?


To: telephonics who wrote (31)12/14/2001 4:04:21 PM
From: W Shakespeare  Respond to of 96
 
I think we may see more volatility as a result of the options (as if this stock is not volatile enough already). The stock continues to raise its trading range and I think more institutions may be finding this stock on their radar screen(check out www.nasdaq.com). There has been a large rise in the percentage of institutional holdings over the last year and I see that trend continuing. Now if we could just get an announcement of a partner for sales and distribution in Europe. . .



To: telephonics who wrote (31)12/24/2001 12:05:00 PM
From: Toby Zidle  Read Replies (1) | Respond to of 96
 
The listing of CPTS options on the AMEX is slightly positive.

First, it means that CPTS passes a volatility threshold. Stocks that are non-volatile have no appeal to options traders, so would be undesirable for listing. Whether volatility, per se, is positive or not is up to your own interpretation.

Second, it probably indicates some statistical measure of long-term uptrend. Since call volume overwhelms put volume, a laggard stock is less likely to generate enough option volume to justify a new options trading listing. Thus, trend prospects for CPTS must be positive.